Cite
HARVARD Citation
Evans, M. et al. (2018). An indirect treatment comparison of the efficacy of insulin degludec/liraglutide (IDegLira) and insulin glargine/lixisenatide (iGlarLixi) in patients with type 2 diabetes uncontrolled on basal insulin. Journal of medical economics. pp. 340-347. [Online].